Stockreport

CTI Biopharma completes patient enrollment in Phase 2 PAC203 study of pacritinib [Seeking Alpha]

CTI BioPharma Corp.  (CTIC) 
Last cti biopharma corp. earnings: 11/1 08:00 am Check Earnings Report
US:NASDAQ Investor Relations: ctibiopharma.com
PDF CTI Biopharma completes patient enrollment in Phase 2 PAC203 study of pacritinib [Read more]